Cargando…
Chronic inhibition of tumor cell-derived VEGF enhances the malignant phenotype of colorectal cancer cells
BACKGROUND: Vascular endothelial growth factor-a (VEGF)-targeted therapies have become an important treatment for a number of human malignancies. The VEGF inhibitors are actually effective in several types of cancers, however, the benefits are transiently, and the vast majority of patients who initi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658959/ https://www.ncbi.nlm.nih.gov/pubmed/23651517 http://dx.doi.org/10.1186/1471-2407-13-229 |